Some Samples of Eye Drops in Different Types of Packaging

To reduce the unwanted effects due to the drug being absorbed into the blood circulation, the inner diameter of the dropper needs to be standardized so that the droplet volume in the eye has a volume of about 30 to 50 µm.

Figure 5.1. Some samples of eye drops packaged in different types of packaging

3. Techniques for preparing and manufacturing eye drops

3.1. Factory and equipment

Eye drops are sterile preparations. Therefore, the facilities and equipment used in the preparation and production of eye drops are basically the same as those used for the preparation and production of injections (see the section on facilities and equipment used for the preparation and production of injections).

3.2. Preparation process

The process of preparation and manufacture of an eye drop involves the same steps as those described in the process of preparation and manufacture of an injection (see diagram 4.5 on page 86). Care must be taken to closely control all steps in the manufacturing process.

3.2.1. Preparation of facilities, equipment, raw materials and packaging

The stages of preparing facilities, equipment, raw materials, packaging and people directly preparing and producing eye drops are exactly the same as the stages of preparing for preparation.

- production of injections.

3.2.2. Preparation

Eye drops solution

When preparing eye drops, pay attention to:

- Dissolve :

If there are no special dissolution requirements, the buffering agent, antiseptic, antioxidant, isotonic agent should be dissolved first, then the drug substance should be dissolved. Dissolution can be carried out at room temperature or by heating the solvent before dissolving, depending on the dissolution properties and the resistance of the substances to heat. When the viscosity-increasing agent, polymer, is added to the eye drop solution, it is necessary to pre-soak the polymer with a certain amount of solvent to allow the polymer to swell and dissolve better.

- Filter solution :

The eye drop solution must be clear and must not contain insoluble particles suspended in the solution. Therefore, after dissolving, the eye drop solution must be filtered through

suitable filter material. To filter eye drop solution, you can use a G 3 , G 4 styrofoam glass funnel or a filter membrane with a pore size of 0.8µm to 0.45µm.

- Sterilization :

The issue of sterilization of eye drops is almost not applied in the current eye drop production process in our country, so this issue needs to be considered. Pharmacopoeia of many countries stipulate that eye drops must be sterilized by appropriate sterilization methods.

To sterilize eye drops, it is possible to sterilize large quantities of solution and then pack the medicine into the smallest possible packaging units, using sterile packaging and bottling in a sterile environment. Or bottling can be done after filtering in the solution and then sterilizing.

Applicable sterilization methods for eye drops:

- Sterilize by moist heat at 121 o C for 20 minutes if the drug and ingredients in the drug are heat-resistant.

- Sterilize by moist heat at 98 - 100 o C for 30 minutes if the eye drops have added antiseptics and the ingredients in the medicine are substances that cannot withstand high temperatures such as chloramphenicol. Cocaine hydrochloride...

- Sterilization by filtration is applicable to eye drops containing heat-labile substances. Use a filter with a pore size of 0.22 µm or smaller and the sterile filtrate must be individually sealed and sterilely packaged, under aseptic conditions.

- Next steps:

- Packing, labeling, packaging finished products and warehousing (only warehousing finished products when tested and meet quality standards).

Eye drops suspension

Although eye drop suspensions have advantages in terms of chemical composition compared to eye drop solutions with the same drug content, the technique of preparing eye drop suspensions is also more complicated.

In eye drop suspensions, poorly soluble solid drugs must be divided into particles smaller than 50 µm in size, so the drug must be used in the form of ultra-fine powder or there must be a suitable drug division device. Eye drop suspensions must be sterile, but to stabilize the size of the drug particles during the preparation process, the product must not be sterilized by heat but must be prepared and manufactured under aseptic conditions.

The diagram (Figure 5.2) briefly describes the sequence of preparation of an eye drop suspension by the dispersion method:

- Use pharmaceutical ingredients in the form of superfine and sterile powder.

- Prepare the carrier solution (dispersion medium): dissolve the ingredients in the drug formula into the solution (if necessary) and sterilize this solution using a suitable sterilization method (filtering to remove bacteria or sterilizing by heat). Note that with polymer components, it is necessary to pre-soak the polymer with a certain amount of solvent to allow the polymer to swell and dissolve better.

Figure 5.2. Flowchart of the preparation of an eye drop suspension

- Creating a pharmaceutical paste: to easily disperse the pharmaceutical into the dispersion medium, the pharmaceutical powder should be mixed with a sufficient amount of the prepared permeable solution or dispersion medium to form a uniform paste.

- Disperse the pharmaceutical paste into the carrier solution using a suitable mixing tool or device. Adjust the volume to the appropriate formula.

- Pass the obtained product through a homogenizer to obtain a homogeneous drug suspension.

- Bottle the finished product.

4. Quality requirements

Eye drops must meet the following criteria:

4.1. Aseptic

- Eye drops must be sterile.

- There are two testing methods: membrane filtration method and direct inoculation method. Proceed according to Appendix 13 in Vietnamese Pharmacopoeia IV (page PL - 266).

4.2. Transparency

- The eye drop solution must be clear, without particles visible to the naked eye.

- Eye drops may settle when standing but must readily disperse homogeneously when shaken and must maintain homogeneity during instillation to ensure correct dosage.

4.3. Particle size

Unless otherwise directed, the eye drops suspension shall comply with the following test: Shake vigorously and transfer a quantity of the preparation equivalent to about 10 µg of the solid phase to a counting chamber or a suitable slide and examine under a microscope of appropriate magnification. Not more than 20 particles shall be greater than 25 µm in size and not more than 2 particles shall be greater than 50 µm in size, and no particle shall be greater than 90 µm in size.

4.4. Other indicators

Parameters such as pH, qualitative, quantitative, viscosity, osmolarity, are carried out according to the instructions in the specific eye drop monographs recorded in DĐVN IV or the manufacturer's standards.

6. Some eye drop formulas

6.1. Catarstat eye drops

Pyridoxine hydrochloride 20mg

Glycine 240mg

Magnesium and potassium salts of aspartic acid 100mg Glutamic acid 380mg

Benzalkonium chloride 10mg

Sodium dihydrogen phosphate v.v.

Disodium hydrogen phosphate v.v.

Distilled water 100m;

6.2. Cebemyxine eye drops

Neomycin sulfate 340,000 IU

Polymycin B sulfate 1,000,000 IU

Other ingredients: dextran, sodium dihydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate, disodium edetate, sodium chloride.

6.3. Timolol 0.1% eye drops

Timolol maleate 136.6mg

(equivalent to 100.0 mg timolol)

Benzalkonium chloride 100mg

Sodium dihydrophosphate dihydrate 24mg

Disodium hydrogen phosphate 100mg

Disodium edetate 10mg

Sodium chloride 46.4mg

β-cyclodextrin 40mg

Propylene glycol 1000mg

Sodium hydroxide or hydrochloric acid pH 6.5 – 7.5. Distilled water 100ml

6.4. Prednisolone acetate eye drops

Prednisolone acetate (very fine powder) 1.0g

Benzalkonium chloride 0.01g

Disodium edetate 0.01g

HPMC 0.5g

Polysorbate 80 0.01g

Isotonic sodium chloride

Sodium hydroxide or hydrochloric acid pH 6.8 – 7.2 Distilled water to 100ml.

6.5. Maxidrol eye drops

Dexamethasone 100mg

Neomycin sulfate 350,000 IU

Polymyxin B sulfate 600,000 IU

HPMC 500mg

Benzalkonium chloride 10mg

Isotonic sodium chloride

Polysorbate 20 vđ

Distilled water 100ml

VALUATION

I. Choose true or false:

1. Absorption of drugs from eye drops through the cornea increases the bioavailability of the drug.

Answer

2. The less irritating the eye drops are, the longer they stay in the eye.

3. Sterilized eye drops after preparation do not need additional antiseptic.

4. Buffer solutions with high buffer capacity should be used to adjust the pH of eye drops.

5. Bacterial filtration is a suitable method for eye drops containing heat-labile active ingredients.

6. Disodium edetate reduces the effectiveness of antiseptics contained in eye drop formulations.

7. Benzalkonium chloride is rarely used as an antiseptic in eye drops.

8. The permeability of the drug increases when the eye drops contain surfactant ingredients. Answer:

9. Among vegetable oils, castor oil is rarely used as a solvent for making eye drops.

10. To ensure safety in use, eye drops must be prepared in a sterile environment and must not be sterilized after preparation.

II. Fill in the blanks:

1. The eye drop solution must be ...(A)..., ....(B).... observable with the naked eye.

2. When the temperature increases, ....(A)..... of MC in water decreases and ....(B)...., but when cooled it does not completely dissolve again as before.

3. There are three routes of drug administration in the treatment of eye diseases: A. .......... B. ................

C. Systemic medication

4. The physiological activity of tears as a natural barrier reduces the effectiveness of eye drops due to:

A. .............................. B. ................. ....

5. There are two types of solvents for making eye drops: .....(A).... and ....(B)....

6. It is possible to increase the permeability of the cornea to the drug by adding ..........(A).......... to the eye drops or adjusting the pH so that the proportion of the drug in the form of ....(B)... is highest while the drug remains stable.

7. After mixing, eye drops can be sterilized in the following two ways: A. ..................... B. .....................

8. There are two cellulose derivatives commonly used to increase the viscosity of eye drops:

...........(A)........... and .........(B).......

9. The main ingredients of Cebemyxine eye drops are: .... (A)..... and .....(B)....

10. There shall be no more than ...(A).... larger than 25µm and no more than ...(B).... larger than 50µm, ...(C).... larger than 90µm.

III. Choose the best answer:

1. Vegetable oil solvents used to prepare eye drops must be sterilized at temperatures:

A. From 135 0 C to 140 0 C

B. From 120 0 C to 125 0 C

C. From 115 0 C to 120 0 C

D. From 100 0 C to 115 0 C

2. Glassware used to prepare eye drops must be boiled in distilled water for 30 minutes and then steamed at 120 0 C in:

A. 10 minutes

B. 30 minutes

C. 20 minutes

D.15 minutes

3. Glassware used to prepare eye drops should be boiled in distilled water for 30 minutes and dried again at 160 0 C to 180 0 C in:

A. 3 hours

B. 2 hours

C. 1 hour

D. 4 hours

4. In the Maxidrol eye drops formula, Polysorbate 20 is:

A. Disinfectant

B. Antioxidants

C. Surfactants

D. Isotonic substances

5. In eye drops formula HPMC is used as:

A. Disinfectant

B. Viscosity enhancer

C. Isotonic substances

D. Antioxidants

6. In the formula of Timolol 0.1% eye drops, NaH 2 PO 4 and Na 2 HPO 4 are used as:

A. Isotonic substances

B. Disinfectant

C. Buffer system

D. Viscosity enhancer.

7. Surfactants are added to eye drops to:

A. Increase the solubility of poorly soluble drugs

B. Increase the stability of the drug

C. Increase corneal permeability to drugs

D. Increase solubility and permeability of drugs.

8. The buffer system that has both buffering and antioxidant synergistic effects is:

A. Glutamic/ glutamate B. Acetic/ Acetate

C. Citric/ citrate D. Boric/ borate

9. The structure of Prednisolone acetate eye drops is:

A. Suspension B. Solution

C. Emulsion D. Colloidal solution

10. The first priority in adjusting the pH of eye drops is:

A. Does not cause eye irritation

B. Keep the drug stable

C. Increase the solubility of the drug

D. To allow the drug to penetrate the cornea.

IV. Answer the following questions:

1. Name the dosage forms used in ophthalmology today?

2. Describe the technique of preparing eye drops and eye drop suspensions?

3. Compare eye drops with injections and infusions in terms of: Active ingredients and excipients?

4. Analyze the composition, formulation, method of preparation and system structure of the following eye drops:

a. Cebemyxine eye drops

Neomycin sulfate 340,000 IU

Polymycin B sulfate 1,000,000 IU

Other ingredients: dextran, sodium dihydrogen phosphate dihydrate, disodium hydrogen phosphate dodecahydrate, disodium edetate, sodium chloride.

b. Maxidrol eye drops

Dexamethasone 100mg

Neomycin sulfate 350,000 IU

Polymycin B sulfate 600,000 UI HPMC 500mg


10mg

Sodium chloride

etc.

isotonic

Polysorbate 20


etc.

Distilled water etc.


100ml

Maybe you are interested!

Benzalkonium chloride

5. Analyze the composition, formula and preparation sequence of the following eye drops:

a. Ophtiole Rp eye drops:

Berberine hydrochloride 0.05g Cyclometazoline HCl 0.05g HPMC 0.1g

Thiomelsal 0.02g

Boric acid 1.8g

NaOH or HCl solution pH 4.5-5.0 Sterile water for injection q.s. 100ml

b. Tobra eye drops contain the following ingredients: Tobramycin, BK, Boric acid, Tyloxapol, Na 2 SO 4 anhydrous, NaCl, NaOH/ H 2 SO 4 solution, pH 7.0-8.0, Water for injection, etc.

6. Describe the role of excipients: Chlorobutanol, NaCl, BK, mercury salts, MC and HPMC used in eye drops?

7. Take some examples of eye drops currently available on the market such as: V-Rhoto, Polydexa, Ivis to practice analyzing and building a formulation process.


Comment


Agree Privacy Policy *